(Q43296441)

18 November 2017

ABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patients (English)

1 reference

18 November 2017

1 reference

10

1 reference

18 November 2017

8

Liliana Dell'Osso

1 reference

18 November 2017

7

Romano Danesi

1 reference

18 November 2017

9

Mario Del Tacca

1 reference

18 November 2017

2

Marianna Lastella

1 reference

18 November 2017

5

Laura Ciofi

1 reference

18 November 2017

Giorgio Consoli

1

1 reference

18 November 2017

Antonio Ciapparelli

series ordinal

3

1 reference

18 November 2017

Mario Catena Dell'Osso

series ordinal

4

1 reference

18 November 2017

Emanuele Guidotti

series ordinal

6

1 reference

18 November 2017

1 August 2009

1 reference

18 November 2017

1 reference

18 November 2017

10

1 reference

18 November 2017

8

1 reference

18 November 2017

1267-1276

1 reference

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

18 November 2017

1 reference

Augmentation strategies in clozapine-resistant schizophrenia

21 January 2018

1 reference

Optimal dosing of atypical antipsychotics in adults: a review of the current evidence

21 January 2018

1 reference

Therapeutic monitoring of new antipsychotic drugs

21 January 2018

1 reference

Serum clozapine levels: a review of their clinical utility

21 January 2018

1 reference

Evidence from a population pharmacokinetics analysis for a major effect of CYP1A2 activity on inter- and intraindividual variations of clozapine clearance

21 January 2018

1 reference

Clozapine, norclozapine plasma levels, their sum and ratio in 50 psychotic patients: influence of patient-related variables

21 January 2018

1 reference

Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: a predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patients

21 January 2018

1 reference

Plasma clozapine concentration coefficients of variation in a long-term study

21 January 2018

1 reference

The cytochrome P450 CYP1A2 genetic polymorphisms *1F and *1D do not affect clozapine clearance in a group of schizophrenic patients

21 January 2018

1 reference

The human ATP-binding cassette (ABC) transporter superfamily

21 January 2018

1 reference

Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense

21 January 2018

1 reference

Identifying candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene

21 January 2018

1 reference

1199G>A and 2677G>T/A polymorphisms of ABCB1 independently affect tacrolimus concentration in hepatic tissue after liver transplantation

21 January 2018

1 reference

Polymorphisms of the ABCB1 gene are associated with the therapeutic response to risperidone in Chinese schizophrenia patients.

21 January 2018

1 reference

In vitro P-glycoprotein affinity for atypical and conventional antipsychotics

21 January 2018

1 reference

Metabolic drug interactions with newer antipsychotics: a comparative review.

21 January 2018

1 reference

Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects.

21 January 2018

1 reference

Power and sample size calculations. A review and computer program

21 January 2018

1 reference

MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity

21 January 2018

1 reference

Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation

21 January 2018

1 reference

A New Statistical Method for Haplotype Reconstruction from Population Data

21 January 2018

1 reference

Pharmacogenetics in transplant patients: can it predict pharmacokinetics and pharmacodynamics?

21 January 2018

1 reference

The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans

21 January 2018

1 reference

The role of the transporter P-glycoprotein for disposition and effects of centrally acting drugs and for the pathogenesis of CNS diseases

21 January 2018

1 reference

Relationship between patient variables and plasma clozapine concentrations: a dosing nomogram.

21 January 2018

1 reference

Expression of a multidrug-resistance gene in human tumors and tissues

21 January 2018

1 reference

Impact of drug transporter studies on drug discovery and development

21 January 2018

1 reference

Evaluation of the role of P-glycoprotein in the uptake of paroxetine, clozapine, phenytoin and carbamazapine by bovine retinal endothelial cells

21 January 2018

1 reference

P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs

21 January 2018

1 reference

The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the MDR1A/1B knockout mouse model

21 January 2018

1 reference

Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds--implications for pharmacokinetics of selected substrates

21 January 2018

1 reference

Pharmacogenetic prediction of clozapine response

21 January 2018

1 reference

Association of Multidrug Resistance in Epilepsy with a Polymorphism in the Drug-Transporter GeneABCB1

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/PGS.09.51

1 reference

18 November 2017

1 reference